A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

BACKGROUND: Patients recruited in randomized controlled trials (RCTs) for biologic therapies in psoriasis are not fully representative of the real‐world psoriasis population. OBJECTIVES: Firstly, to investigate whether patient characteristics are associated with being included in a psoriasis RCT. Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiu, Z.Z.N., Mason, K.J., Barker, J.N.W.N., Hampton, P.J., McElhone, K., Smith, C.H., Warren, R.B., Griffiths, C.E.M., Lunt, M., Burden, A.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916305/
https://www.ncbi.nlm.nih.gov/pubmed/30822358
http://dx.doi.org/10.1111/bjd.17849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916305/
https://www.ncbi.nlm.nih.gov/pubmed/30822358
http://dx.doi.org/10.1111/bjd.17849

Ejemplares similares